早期系统性硬化症患者便代谢的表征
Arissa C Young1, Kristofer Andréasson2, Jennifer Labus1
1University of California, Los Angeles.
ACR open rheumatology
|November 12, 2025
概括
在早期系统性硬化症 (SSc) 中,肠道微生物组及其代谢物发生变化. 患有SSc的患者表现出与特定肠道细菌相关的短链脂肪酸 (SCFA) 的增加.
科学领域:
- 微生物组研究的研究.
- 代谢学 代谢学 代谢学
- 系统性硬化症 (SSc) 是一种疾病.
背景情况:
- 系统性硬化症 (SSc) 是一种以纤维化为特征的自身免疫性疾病.
- 人们越来越认识到肠道微生物组在SSc病变发生中的作用.
- 在早期的SSc中,便代谢物概况仍未得到充分研究.
研究的目的:
- 将早期SSc患者的便代谢组与健康对照组进行比较.
- 调查改变的便代谢物和早期SSc.中的特定细菌属之间的关联.
主要方法:
- 收集了106名早期SSc患者和79名对照者的便样本和临床数据.
- 利用液体染色学-质谱仪用于目标代谢学.
- 采用16S rRNA基因测序来分析便中的微生物组成.
主要成果:
- 早期的SSc患者表现出更高的尼古丁胺,5'-甲基腺素和短链脂肪酸 (SCFA),如酸,酸和酸.
- 相反,SSc患者表现出较低的西龙酸,酸盐,甲酸硫化物和酸盐的水平.
- SCFA与不同的细菌属有关,其中一些在SSc患者中更为丰富.
结论:
- 便新陈代谢在早期的SSc中发生显著变化.
- 一个显著的转向增加的SCFA特征在早期的SSc便代谢.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...


